Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.

ABSTRACT:

Background

Flibanserin, approved for the treatment of hypoactive sexual desire disorder (HSDD) in females, has demonstrated diverse therapeutic and adverse effect (AE) prospects in the extant randomized controlled trials (RCTs). This meta-analysis aimed to characterize the outcomes of flibanserin use in these patients comprehensively.

Methods

RCTs involving women with HSDD receiving flibanserin in the intervention arm and placebo in the control arm were sought after throughout the electronic databases. The primary outcomes were the changes from baseline in satisfying sexual events (SSE) per month and sexual desire score per month measured using an electronic diary (eDiary).

Results

From 478 initially screened articles, data from 8 RCTs involving 7906 women with HSDD w

SUBMITTER: Kamrul-Hasan ABM 

PROVIDER: S-EPMC11192006 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature